Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03897296
Other study ID # HRAM-HV
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 15, 2019
Est. completion date April 15, 2024

Study information

Verified date February 2022
Source Russian Academy of Medical Sciences
Contact Sergey Morozov, MD, PhD
Phone +74996131091
Email morosoffsv@mail.ru
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

High resolution anorectal manometry (HRAM) normative values are still need to be studied in different populations and with the use of different (solid-state and water-perfused) systems. No studies on HRAM normative values in a Russian population without signs of functional and organic anorectal pathology has been carried out yet.


Description:

High-resolution anorectal manometry (HRAM) is a modern technique used to evaluate the function of the rectum and its sphincters. It is intended to measure the resting pressure in the anal canal, as well as pressure during voluntary contraction of the external anorectal sphincter and pelvic floor muscles and to evaluate reactions to the functional tests. Several studies have been performed to evaluate normative metrics of anorectal manometry to the moment, but most of them enrolled patients living in the US and countries of the Western Europe. Nutritional patterns, ethnic composition of the population and other factors may cause the differences in the mormative values of HRAM in different populations. Current study is organized to evaluate normative metrics of HRAM in a Russian healthy cohort.


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date April 15, 2024
Est. primary completion date April 15, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Willingness to participate in this clinical trial, confirmed by signed informed consent form. - Patients of both sexes, aged 18 to 65 years inclusive. - Permanent residence in the Russian Federation (capable citizens of Russia on the basis of a passport of a citizen of the Russian Federation). - Absence of rectal diseases, confirmed by the results of clinical and instrumental examinations - Ability to follow the instructions when high-resolution anorectal manometry procedure is performed. Exclusion Criteria: - Known diseases of the rectum on the basis of clinical and / or instrumental examination, including presence of complaints to difficulties with defecations that require manual aids or use of laxatives; - Surgical interventions on pelvic organs in history; - History of organ transplantation except for corneal transplantation and eye lens replacement surgery; - Oncology of any localization, with the exception of skin cancer in situ; - Severe concomitant pathology of any organs and systems, which, in the opinion of the researcher, makes it impossible to carry out the procedure of high-resolution anorectal manometry or if the procedure may cause the risk of worsen the patient's condition; - Absence of anamnestic, clinical and laboratory signs of alcohol abuse (abuse will be considered in case of the use of more than 30 g of pure alcohol per day by males and the use of more than 20 g of pure alcohol per day by females; - Use of illegal drugs, including history; - Use of concomitant medications that can affect the motor function of the colon (including, but not limited to: calcium channel blockers, metoclopramide, m-cholinolytics, domperidone, nitrates, tricyclic antidepressants, opiates, beta-blockers, beta-adrenomimetics, alcohol). The duration of the period of non-use of these drugs should provide sufficient time for the complete cessation of their pharmacological action, but not less than two half-life periods. - Pregnancy and breast-feeding; - Technical impossibility to insert the catheter due to the previously known or current poor tolerability of high-resolution anorectal manometry procedure or due to the presence of anatomical features that make it impossible to insert the catheter. Criteria of non-inclusion of the data to the analysis: - Patients may choose to stop their participation in the study by withdrawal of their previously signed consent, that leads to the exclusion of their data from the analysis. The researcher should be guided by the following criteria, however, he may at any time terminate the patient's participation in the study on the basis of his own clinical judgment. Cancellation of participation in the study can be carried out on the basis of the following events: 1. Lack of the possibility to insert water-perfused catheter during high-resolution anorectal manometry procedure due to anatomical features or psychological state of the patient. 2. Incomplete high-resolution anorectal manometry procedure. 3. Presence of adverse event(s) during high-resolution anorectal manometry procedure, causing the further procedure impossible. 4. Obtaining incomplete recording of high-resolution anorectal manometry parameters for any reason. 5. Identification of the conditions described in the section "exclusion criteria" during examination of the patient.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
High resolution anorectal manometry, water perfused catheter
High resolution anorectal manometry with the use of water-perfused catheter will be performed to eligible subjects willing to participate in the study

Locations

Country Name City State
Russian Federation Gastroenterology and Hepatology, FRC Nutrition and Biotechnology Moscow
Russian Federation State Scientific Center of Coloproctology Moscow

Sponsors (3)

Lead Sponsor Collaborator
Russian Academy of Medical Sciences Federal Research Centre of Nutrition and Biotechnology, State Scientific Centre of Coloproctology, Russian Federation

Country where clinical trial is conducted

Russian Federation, 

Outcome

Type Measure Description Time frame Safety issue
Primary Resting anorectal pressure obtained with the use of water-perfused catheter for high-resolution anorectal manometry Anorectal pressure at rest, mm Hg 1 minute
Primary Maximal squeeze pressure obtained with the use of water-perfused catheter for high-resolution anorectal manometry Maximal pressure when a squeeze test is performed, mm Hg 5 seconds
Primary Maximal pressure of endurance squeeze test performed with the use of water-perfused catheter for high-resolution anorectal manometry mean pressure during test, mm Hg 30 seconds
Primary Push test pressure obtained with the use of water-perfused catheter for high-resolution anorectal manometry mean pressure during push test, mm Hg 5 seconds
Primary Cough test Cough test pressure, maximal 5 seconds
Primary Pressure of the first sensation obtained with the use of water-perfused catheter for high-resolution anorectal manometry Pressure of the first sensation by the test of reservoir function of the rectum, mm Hg 1 minute
Primary Pressure of the urge to defecate obtained with the use of water-perfused catheter for high-resolution anorectal manometry Pressure of the urge to defecate by the test of reservoir function of the rectum, mm Hg 1 minute
Primary Maximal tolerate volume pressure obtained with the use of water-perfused catheter for high-resolution anorectal manometry Maximal tolerate volume pressure by the test of reservoir function of the rectum, ml 1 minute
Primary First pain sensation pressure obtained with the use of water-perfused catheter for high-resolution anorectal manometry Appearance of pain sensation by the test of reservoir function of the rectum, mm Hg 1 minute
See also
  Status Clinical Trial Phase
Completed NCT05483998 - A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants Phase 1
Recruiting NCT02417714 - Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
Recruiting NCT02235012 - Cognitive Biases Under Ketamine N/A
Completed NCT05088343 - Effect of Hetrombopag on the Pharmacokinetics of Rosuvastatin in Healthy Subjects Phase 1
Completed NCT04418973 - Analysis of Breath Volatile Organic Compounds After Dyspnea Induced in the Healthy Subject. N/A
Not yet recruiting NCT06248801 - Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets Phase 1
Terminated NCT04068259 - Single Ascending Dose Study of PBI-4547 in Healthy Subjects Phase 1
Completed NCT03279302 - Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects Phase 1
Not yet recruiting NCT06233162 - Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets Phase 1
Recruiting NCT04159844 - Evaluation of the Stiffness and Pressure Applied on the Lower Leg by a New Compression Bandage on Healthy Subjects N/A
Completed NCT06137911 - Evaluation of Safety, Tolerability & Pharmacokinetics of JYP0061 in Healthy Adults. Phase 1
Completed NCT04849286 - Measurement of HTL0016878 in Cerebrospinal Fluid Phase 1
Not yet recruiting NCT06233227 - Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule Phase 1
Completed NCT04096157 - A Study to Assess Isavuconazole Following a Single Dose of Isavuconazonium Sulfate Intravenous Solution Via Nasogastric (NG) Tube Compared to a Single Dose of Oral Capsules Under Fasting Conditions in Healthy Participants Phase 1
Completed NCT01200368 - Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants Phase 3
Recruiting NCT05805033 - Peri-Implant Soft Tissue Integration in Humans: Influence of Material N/A
Completed NCT04027803 - Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Single Intravenous Doses of BCD-148 and Soliris® Phase 1
Recruiting NCT03467880 - Multicenter Study of Impulse Oscillometry in Chinese N/A
Completed NCT02903095 - Single Ascending Dose Study of TD-1439 in Healthy Subjects Phase 1
Active, not recruiting NCT02341508 - A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Lpathomab in Healthy Volunteers Phase 1